Fate Therapeutics Inc (NASDAQ: FATE): Analyst View Points To Future Growth
Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $3.90, with 3.9 million shares of worth about $15.22 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 68.83% during that period and on May 09, 2024 the price saw a […]
Set Your Sights On Fate Therapeutics Inc (NASDAQ: FATE)’S Upside Potential
Fate Therapeutics Inc (FATE) concluded trading on Wednesday at a closing price of $4.09, with 4.33 million shares of worth about $17.7 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 136.42% during that period and on May 01, 2024 the price saw a […]
An Important Check-Up On Fate Therapeutics Inc (NASDAQ: FATE)
Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $5.04, with 2.33 million shares of worth about $11.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 149.50% during that period and on April 18, 2024 the price saw a […]
Is There More Upside Ahead For Fate Therapeutics Inc (NASDAQ: FATE)
Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $8.35, with 3.89 million shares of worth about $32.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 221.15% during that period and on Thursday the price saw a gain of […]
Fate Therapeutics Inc (NASDAQ: FATE): Stock That Needs Special Handling
Currently, there are 98.63M common shares owned by the public and among those 86.10M shares have been available to trade. Insiders at the company have transacted a total of 11 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 3 of these insider trades were purchases, […]
Set Your Sights On Fate Therapeutics Inc (NASDAQ: FATE)’S Upside Potential
Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $7.08, with 2.91 million shares of worth about $20.58 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 153.76% during that period and on Thursday the price saw a gain of […]
Following The Money: Institution’s Growing Stake In Fate Therapeutics Inc (NASDAQ: FATE)
Fate Therapeutics Inc (FATE) concluded trading on Thursday at a closing price of $6.11, with 2.8 million shares of worth about $17.12 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 79.71% during that period and on Thursday the price saw a gain of […]
Analyst Expect Big Moves From Fate Therapeutics Inc (NASDAQ: FATE)
Redmile Group LLC recently announced the acquisition of new stake in Fate Therapeutics Inc (NASDAQ:FATE). The institutional investor has increased its shareholding in the Healthcare company by 0.43% to 13.18 million shares with purchase of 55961.0 shares. This fresh investment now brings its stake to 13.37% valued currently at $49.29 million. In addition, BlackRock Fund […]
Fate Therapeutics Inc (NASDAQ: FATE) Not A Good Play Anymore?
Redmile Group LLC has recently announced that it has increased stake in Fate Therapeutics Inc (NASDAQ:FATE) by 0.43%. After grabbing 13.18 million shares, the institutional investor is now in possession of 55961.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.37% having worth around $49.29 million. Moreover, BlackRock […]
Fate Therapeutics Inc (FATE): Insights At A Glance
Redmile Group LLC has recently announced that it has increased stake in Fate Therapeutics Inc (NASDAQ:FATE) by 0.43%. After grabbing 13.18 million shares, the institutional investor is now in possession of 55961.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.37% having worth around $32.82 million. Moreover, BlackRock […]
